In the human system, the key function of regulating blood sugar levels is carried out by not only insulin but another vital hormone as well, known as glucagon. Glucagon is a peptide hormone synthesized by the alpha cells in the pancreas, and it is primarily involved in preventing blood glucose levels from decreasing to very low amounts. When blood sugar count reduces significantly, it leads to a condition called hypoglycemia.
The pancreas is a pivotal gland in the human body, extending for about 6 inches in length with a flattened structure and situated at the back of the abdomen behind the stomach. It encompasses specialised cells known as Islets of Langerhans, within which the alpha cells produce glucagon and the beta cells make insulin. The alpha cells are arranged adjacent to and all around the beta cell, signifying how insulin and glucagon work closely together to control blood glucose levels in the system.
Also Read: Insulin: Structure, Crucial Functions And Adverse Effects
Glucagon And Its Structure:
Within the body, in times of low blood glucose - hypoglycemia, glucagon secretion is activated in the pancreas. The hormone then prompts the synthesis of glucose from glycogen stores in the liver, as well as amino acid components, to subsequently normalize blood sugar levels and restore optimal metabolism. Similarly, when blood glucose levels increase considerably - hyperglycemia, the secretion of insulin is kindled in the pancreas and the hormone enhances the uptake of glucose by cells, to lower blood sugar concentrations to the normal range. Insulin and glucagon exert their hormonal effects on the body by counterbalancing one another’s actions and thus help maintain normal blood sugar levels.
Glucagon was discovered by renowned American physiologists and scientists from the University Of Rochester in New York - C.P. Kimball and John Murlin in 1923, upon conducting detailed experiments on pancreatic extracts. They found a novel compound that showcased hyperglycemic properties and labelled it as “Glucagon”, derived from the term “Glucose Agonist”, which described its effects and functions. Further research on the structure and function of glucagon revealed its amino acid sequence as well as its role in increasing blood glucose levels later on in the period between the 1950s to 1970s.
Glucagon is a polypeptide hormone composed of 29 amino acids. The primary structure of glucagon in the human system is: NH2-His-Ser-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Lys-Tyr-Leu-Asp-Ser-Arg-Arg-Ala-Gln-Asp-Phe-Val-Gln-Trp-Leu-Met-Asn-Thr-COOH. It has a molecular weight of 3485 Da (Da – dalton, being the fundamental unit of atomic mass).
Functions Of Glucagon:
The major function of glucagon in the human body is to increase the amount of glucose in blood circulation. The peptide hormone performs this important task by two specific intrinsic mechanisms. When blood glucose drops to very low levels, glucagon is synthesised in the alpha cells of the pancreas and released into the bloodstream, wherein it activates crucial metabolic activities in the liver. These comprise:
Breakdown Of Glycogen Stored In The Liver - Glycogenolysis:
When the amount of glucose in the blood is very high, the surplus is stored in the liver. Insulin mediates this mechanism and stores the glucose in the form of glycogen within the hepatic cells. Following this, when blood glucose levels decrease to very low amounts, glucagon is secreted and exerts its influence on the liver cells to break down glycogen into glucose and subsequently release it into circulation, thereby regulating blood sugar levels.
Synthesis Of Glucose From Amino Acids In The Liver - Gluconeogenesis:
When blood sugar levels reduce to very low numbers, then glucagon activates a vital mechanism in the liver termed gluconeogenesis. This process involves the synthesis of glucose from amino acid molecules in the liver and then releasing it into the bloodstream to restore normal blood sugar levels.
Adverse Effects Of Hormonal Imbalance In Glucagon:
Low Levels:
Glucagon is generally tightly regulated by the pancreas and brain cells in the body, and its levels usually do not decrease much.
However, a rare situation arises in babies wherein very low levels of glucagon are present in the system, which leads to instances of low blood glucose and the condition can be resolved only by administering glucagon injections.
High Levels:
Very high levels of glucagon occur only rarely when a tumour forms in the alpha cells of the pancreas – a disease known as glucagonoma.
It leads to diabetes mellitus, skin rashes, weight loss, and blood clotting disorders such as venous thrombosis.
Frequently Asked Questions
What Are The Adverse Effects Of Glucagon?
Glucagon can cause some side effects, especially when used as an emergency medication for severe low blood sugar. Common adverse effects include:
Nausea
Vomiting
Headache
Dizziness
Temporary increase in heart rate
High blood sugar after use
Injection site irritation (for injectable forms)
Rare but serious reactions may include allergic reactions or breathing difficulty. Medical attention is recommended if severe symptoms occur.
What Is The Structure Of Glucagon?
Glucagon is a peptide hormone made up of 29 amino acids arranged in a single chain. It is produced by the alpha cells of the pancreas. Its molecular structure allows it to bind to glucagon receptors, mainly in the liver, where it helps regulate blood sugar levels.
What Is Glucagon And Its Functions?
Glucagon is a hormone produced by the pancreas that helps raise blood glucose levels when they fall too low. It works opposite to insulin.
Main functions of glucagon include:
Stimulates the liver to release stored glucose.
Promotes breakdown of glycogen into glucose.
Supports the production of new glucose (gluconeogenesis).
Helps maintain energy supply during fasting.
Prevents dangerously low blood sugar levels.
What Is The Main Effect Of Glucagon?
The main effect of glucagon is to increase blood sugar levels by signalling the liver to release glucose into the bloodstream. This is especially important during fasting, exercise, or hypoglycemia.
References:
Glucagon Physiology
Iben Rix, Christina Nexøe-Larsen, Natasha C Bergmann, Asger Lund, und Filip K Knop.
https://www.ncbi.nlm.nih.gov/books/NBK279127/
https://www.sciencedirect.com/science/article/pii/S0021925819431360
Previous
